Vascular Biogenics Ltd has Semi Deviation of 3.54, Coefficient Of Variation of 645.05 and Risk Adjusted Performance of 0.01. In relation to Fundamental Indicators, Macroaxis technical analysis interface makes it possible for you to check existing technical drivers of Vascular Biogenics as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past prices and volume data or the prices will eventually revert. We found nineteen technical drivers for Vascular Biogenics Ltd which can be compared to its competition. Please validate Vascular BiogenicsJensen Alpha and Semi Variance to decide if Vascular Biogenics is priced more or less accurately providing market reflects its prevalent price of 2.8 per share. Please also confirm Vascular Biogenics Ltd Total Risk Alpha which is currently at 0.0 to double-check the company can sustain itself at future point.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vascular Biogenics volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Vascular Biogenics Trend Analysis
Use this graph to draw trend lines for Vascular Biogenics Ltd. You can use it to identify possible trend reversals for Vascular Biogenics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vascular Biogenics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Vascular Biogenics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Vascular Biogenics Ltd applied against its price change over selected period. The best fit line has a slop of 0.05 % which means Vascular Biogenics Ltd will continue generating value for investors. It has 34 observation points and a regression sum of squares at 2.26, which is the sum of squared deviations for the predicted Vascular Biogenics price change compared to its average price change.
Did you try this?
Run Equity Analysis Now
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities